Drugs / Eto
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01429610 Background | Nov 2011 → Jan 2018 | precursor lymphoblastic lymphoma/leukemia | Asan Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eto | “Eto 150 mg/m2/d iv over 3 hr (d1-4)” NCT01429610 ↗ |
| Route | Intravenous | “Eto 150 mg/m2/d iv over 3 hr” NCT01429610 ↗ |